New Delhi, April 20
Prime Minister Narendra Modi on Tuesday urged the vaccine manufacturers to continuously scale up the production capacity to vaccinate countrymen in the shortest possible time.
Believing in the ability of the vaccine manufacturers, PM Modi said, "The government has now allowed the vaccination programme for every adult starting May 1."
He urged the vaccine manufacturers to continuously scale up the production capacity to vaccinate the people in the shortest possible time. He also appreciated the efforts and studies being conducted by Indian scientists for the development of new vaccines.
Modi credited the vaccine manufacturers for developing and producing vaccines in record time. Noting the fact that vaccines manufactured here are the cheapest, he said the world's largest vaccination programme is underway in India. He remarked that throughout this process of developing and manufacturing vaccines, the country has constantly worked with the spirit of public-private partnership under the 'Mission Covid Suraksha', and created an end-to-end vaccine development ecosystem.
"The Government ensured that all the vaccine manufacturers not only get all possible help and logistic support, but also the process of vaccine approval is speedy and scientific," the Prime Minister said. He assured all possible support and a smooth approval process for the vaccine candidates which are currently in the trial phase.
The Prime Minister said the health infrastructure of our private sector has played a big role in the country's fight against Covid-19 and in the coming days, the private sector will play an even more active role in the vaccination drive and this will require better coordination between hospitals and industry.
The vaccine manufacturers thanked the Prime Minister for the Government's decision of allowing vaccination for everyone above the age of 18 and various steps taken to give more incentives and flexibility. They also appreciated Modi's leadership for the support they have received from the Government throughout the process of vaccine development and production. They also discussed their plans to ramp up production, upcoming vaccine candidates and research on the new variants.
Disclaimer: This story was supplied by an external content provider; we do not endorse or accept responsibility for its accuracy, completeness, or any outcomes from relying on it. It is for informational purposes only and does not constitute legal, financial, medical, or other professional advice. Laws and regulations vary and may change; readers should verify accuracy and compliance with local requirements and consult a qualified professional for tailored guidance.